Bleeding complications in critically ill patients with liver cirrhosis

Jaeyoung Cho1, Sun Mi Choi1, Su Jong Yu2

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

Insights

Critically ill patients with liver cirrhosis (LC) face significant bleeding risks in the ICU. Low platelet counts and sepsis are key risk factors for major bleeding events.

Area of Science:

  • Critical Care Medicine
  • Hepatology
  • Hematology

Background:

  • Liver cirrhosis (LC) patients admitted to the Intensive Care Unit (ICU) are prone to critical events.
  • Coagulopathy in LC is complex, increasing risks for both bleeding and thrombosis.
  • Understanding bleeding complications in these patients is crucial for improving outcomes.

Purpose of the Study:

  • To investigate the incidence and risk factors of major bleeding complications.
  • To assess the outcomes of critically ill patients with liver cirrhosis admitted to a medical ICU (MICU).

Main Methods:

  • Retrospective analysis of adult patients diagnosed with LC admitted to a MICU between January 2006 and December 2012.
  • Exclusion of patients with major bleeding at the time of MICU admission.
  • Multivariate analysis to identify independent risk factors for major bleeding.

Main Results:

  • Of 205 patients analyzed, 12.2% experienced major bleeding.
  • Gastrointestinal (64%) and respiratory (20%) tracts were the most common bleeding sites.
  • Low platelet count (OR, 0.98) and sepsis (OR, 8.35) were independent risk factors for major bleeding.
  • ICU fatality rate was significantly higher in patients with major bleeding (84.0%) compared to those without (58.9%).

Conclusions:

  • Major bleeding affects over 12% of critically ill cirrhotic patients in the MICU.
  • Low platelet count and sepsis are significant predictors of major bleeding.
  • Further research is warranted to elucidate hemostasis mechanisms in critically ill LC patients.
Abstract

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
752
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
371
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
333
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.0K